Dr Penny Woods, Chief Executive of the BLF today commented on some - TopicsExpress



          

Dr Penny Woods, Chief Executive of the BLF today commented on some new drug trials for IPF patients: “We welcome the results of the trials presented at ATS this year and we hope that they will take us a step further in treating patients and understanding the devastating disease that is IPF. “The level of knowledge and understanding of IPF seriously lags behind that of other diseases. Only a significant increase in research investment will help bring about the improvements needed to bridge this gap and bring IPF treatment into the 21st century.”
Posted on: Mon, 19 May 2014 15:48:18 +0000

Trending Topics



Recently Viewed Topics




© 2015